Xstate Resources Ltd
ASX:XST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
Xstate Resources Ltd
ASX:XST
|
AU |
|
B
|
Basilea Pharmaceutica AG Allschwil
SWB:PK5
|
CH |
|
Nanophase Technologies Corp
OTC:NANX
|
US |
|
Suzhou Weizhixiang Food Co Ltd
SSE:605089
|
CN |
|
Mindteck (India) Ltd
NSE:MINDTECK
|
IN |
Balance Sheet
Balance Sheet Decomposition
Xstate Resources Ltd
Xstate Resources Ltd
Balance Sheet
Xstate Resources Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
|
| Cash Equivalents |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
39
|
30
|
12
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
2
+1 145%
|
1
-69%
|
1
+70%
|
1
-53%
|
1
+95%
|
40
+3 595%
|
32
-21%
|
13
-60%
|
5
-64%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
0
|
2
|
3
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
35
|
28
|
10
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-12%
|
0
+58%
|
1
+213%
|
1
-42%
|
0
-42%
|
37
+9 302%
|
31
-15%
|
11
-66%
|
1
-89%
|
|
| Equity | |||||||||||
| Common Stock |
44
|
47
|
48
|
49
|
50
|
50
|
58
|
58
|
58
|
58
|
|
| Retained Earnings |
44
|
45
|
48
|
49
|
50
|
50
|
54
|
57
|
56
|
55
|
|
| Total Equity |
0
N/A
|
2
N/A
|
0
-83%
|
0
-84%
|
0
N/A
|
1
N/A
|
4
+446%
|
1
-82%
|
2
+214%
|
3
+55%
|
|
| Total Liabilities & Equity |
0
N/A
|
2
+1 145%
|
1
-69%
|
1
+70%
|
1
-53%
|
1
+95%
|
40
+3 595%
|
32
-21%
|
13
-60%
|
5
-64%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
238
|
622
|
783
|
1 140
|
1 425
|
181
|
322
|
322
|
322
|
322
|
|